What does hot weather do to the body?
Hot weather during the summer can affect anyone, but some people run a greater risk of serious harm.
Category: Health
Study: Long-term use of CBD supplements lowers aggression in dogs
Dogs who are given supplements containing cannabidiol, or CBD, over a period of years show lowered aggression levels, a new study claims.
Low discontinuation rates confirm manageable safety of iza-bren
An investigational EGFR x HER3 antibody-drug conjugate demonstrated promising efficacy with a tolerable safety profile in patients with previously treated EGFR-mutated non-small cell lung cancer
Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination
The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in patients with small cell lung
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically
The Pitt is up for 25 Emmys – but the show’s biggest fans are real-life doctors
Those in the medical profession say the HBO Max show about a US hospital emergency room is the most realistic medical drama yet.
Why I’m doing a September reset and how you can create a new routine
It’s the month when many of us embark on a new chapter so here’s how to start strong and keep the good habits.
8 activewear brands you should add to your workout wardrobe
The increasing popularity of stylish, trendy athletic wear has made über-comfortable clothing something that’s not just for the gym. It’s infiltrated all corners of culture
Some dentists say more young people are grinding their teeth – are you one of them?
Millions of us do it, though few of us realise we do – but getting the right treatment can be life-changing.
What are the symptoms of meningitis and how is it spread?
Some people can carry bacteria in their nose or throat without getting sick, but can spread it to others.
Subcutaneous tarlatamab exhibits low toxicity rates in phase 1b trial
Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), according to
Phase 2 study highlights flexible dosing options for tarlatamab in relapsed SCLC
Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally consistent with the established every-two-week regimen in patients with previously treated for small
MD Anderson trial challenges local consolidative therapy paradigm in NSCLC
Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or progression-free survival in patients with metastatic non-small